L&C Bio Set to Revolutionize the Aesthetic Medicine Market in the US

L&C Bio Set to Revolutionize the Aesthetic Medicine Market in the US

L&C Bio, a prominent player in the aesthetic medicine sector, is primed for significant growth as it anticipates a successful entry into the United States market. Recent analysis indicates that favorable developments, including regulatory approvals and high sales projections for their innovative product, 'Rituo,' are paving the way for this expansion.

Promising Forecasts for Revenue Growth

According to Kim Ji-young, an analyst at Shinhan Securities, L&C Bio is projected to experience the steepest revenue growth within the aesthetic medicine sector. The expected financial trajectory includes a remarkable increase in sales from 6.1 billion won last year to an impressive forecast of 70.5 billion won for the entire year. This robust growth is credited to the anticipated boost from the U.S. market entry and other strategic advancements.

Strategic Developments and Approvals

The company's optimism is rooted in the recent production approval in China and the commercialization of waste fat, which is expected to have broad applications. The Ministry of Food and Drug Safety's approval for the use of waste fat provides a solid foundation for L&C Bio's new business endeavors. This innovative approach could potentially lead to a significant market size larger than current skin extracellular matrix products.

Entering the US Market

The key highlight for L&C Bio is its imminent entry into the U.S. market. Given the local procedure price for competitive products ranges between $2,000 to $3,000, L&C Bio's pricing strategy, based on lower supply costs, suggests a lucrative opportunity. The average selling price in the U.S. could be ten times higher than in Korea, promising vast potential for profit and widespread adoption of their products.

As L&C Bio prepares to capitalize on these opportunities, the company’s vision for mid- to long-term growth remains a focal point, ensuring that they not only meet current demands but also set the stage for future advancements in the aesthetic medicine landscape.